Nearly 80% of respondents reported DIR fees as a very large magnitude challenge, with 83.3% reporting this as a very immediate challenge. Seventy-eight percent of respondents reported MACs not being updated quickly enough to reflect changes in wholesale drug costs as a very large magnitude challenge, with nearly 80% indicating it as a very immediate challenge.
CVS Health president and CEO Larry Merlo was the guest on Boston’s WBUR radio station’s “Here & Now” Tuesday, speaking with host Jeremy Hobson about such topics as tax reform, Amazon’s potential entry into pharmacy and the ongoing question of what changes will come to health care as the Senate considers the American Health Care Act. “I think there are elements that make sense from the Republican plan, but clearly there are other elements the Republican plan does not deal with,” Merlo said. “I think there are many open questions that have yet to be answered” (WBUR)
Roughly three-quarters of visitors to the online platform are taking active follow-up steps, the retailer announced Tuesday, noting that its digital mental health resources also are reaching a broader demographic of consumers.
“Pharmacists need to understand what’s happening around them regarding the availability of precision medicines and their profiles,” Murray Aitken, executive director of the Quintiles IMS Institute and co-author of the report, said during the International Pharmaceutical Federation 6th Pharmaceutical Sciences World Congress.
Among NCPA’s comments were notes about what it sees as the need to address direct and indirect remuneration, or DIR, fees; requests to standardize how Medicare Part D plans measure pharmacy quality; and other efforts to improve patient access to medication and pharmacy services